Dolores Ochoa Mazarro, MD
Fundación de Investigación Biomédica - Hospital Universitario de La Princesa
2
2
1
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (2)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Ana Maria Aldea Perona, MD
Municipal Institute Of Medical Investigation
Shared therapeutic areas:
Worked with same sponsors:
Rosa Maria Príncipe, MD
Hospital Pedro Hispano
Shared therapeutic areas:
Worked with same sponsors:
Serafim Guimarães, MD
Blueclinical Investigacao E Desenvolvimento Em Saude Lda.
Shared therapeutic areas:
Worked with same sponsors:
Serafim Guimarães
Blueclinical Investigacao E Desenvolvimento Em Saude Lda.
Shared therapeutic areas:
Worked with same sponsors:
Alberto Borobia Pérez, MD
Hospital Universitario La Paz
Shared therapeutic areas:
Worked with same sponsors:
Rosa Maria Antonijoan Arbós, MD
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Shared therapeutic areas:
Worked with same sponsors:
Joana Cochicho, MD
Centro Hospitalar de Vila Nova de Gaia/Espinho
Shared therapeutic areas:
Worked with same sponsors:
Antonio Portolés Pérez, MD
Hospital Clinico San Carlos
Shared therapeutic areas:
Worked with same sponsors:
Daniela Machado Lopes, MD
Centro Hospitalar de Vila Nova de Gaia/Espinho
Shared therapeutic areas:
Worked with same sponsors:
Germán Soriano Pastor, MD
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Shared therapeutic areas:
Worked with same sponsors:
Publications (0)
No publications found for this investigator.
Clinical Trials (2)
Showing 2 of 2 trials
Pharmacokinetics and Safety of Rupatadine in Participants With Renal Impairment Compared to Control Participants
Pharmacokinetics and Safety of Rupatadine in Participants With Hepatic Impairment Compared to Control Participants.
All 2 trials loaded